Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Short on time? Check out these ways to make money in 5 minutes that can help you earn extra cash quickly.
13,498 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
As rates trend higher, investors worry about income and growth. This article explores a dividend ETF designed to weat...
Two industrial names sit at the center of the rare-earth supply story: MP Materials and TMC The Metals Company. This ...
A New York Supreme Court filing brings a human claimant into a case over billions in dormant Bitcoin. The move could ...
A surge in Lemonade's stock grabbed attention as investors weighed renewed reinsurance terms and AI-driven growth. Th...
Two popular healthcare ETFs—IHE and IBB—offer very different routes to exposure: established pharma vs biotech innova...
Gas prices swung in 2026 amid Middle East tensions, lifting refining margins. This article identifies the stocks pois...
When Netflix just reported earnings, the market focused on growth signals, margins, and the path to free cash flow. T...
A U.S. freeskier who once faced a public jab from the president miles ahead in the Olympic season posts a strong qual...
MBA data through Q3 2025 show a persistent profitability split among lenders, with top-tier banks earning far more pe...
Ready to put $1,000 to work in AI? This beginner-friendly guide reveals a simple, diversified approach to the best st...
Investors noticed a notable move in jumia technologies stock jumped this week as Jumia reported improving early resul...